Literature DB >> 31914444

Update on the Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding.

Sophie Restellini1,2, Luc Biedermann3, Petr Hruz4, Christian Mottet5, Annick Moens6, Marc Ferrante6, Alain M Schoepfer7.   

Abstract

Inflammatory bowel disease (IBD) affects patients during their peak reproductive years. This raises important questions, in both patients and healthcare providers, regarding conception, pregnancy, and breastfeeding. Lack of information and insufficient communication among healthcare providers can leave patients with limited information and even contradictory advice. Given the fact that pregnant and/or breastfeeding IBD patients are excluded from clinical studies the evidence on many questions related to pregnancy and postpartum period is limited. However, there exists increasing data from case series and cohort studies that allows to provide clinical guidance. The overarching concept is that optimizing the mother's health is critical for optimizing the health of the unborn child and benefit of continuing medical therapy in IBD during pregnancy outweighs possible risks in most instances. This paper provides an up-to-date systematic review of the literature on IBD in pregnancy and proposes guidance to questions frequently encountered by healthcare professionals.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Breastfeeding; Inflammatory bowel disease; Pregnancy

Mesh:

Year:  2020        PMID: 31914444     DOI: 10.1159/000502886

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  5 in total

1.  Twitter debate: controversies in pregnancy in IBD and liver disease.

Authors:  Aditi Kumar; Catherine Nelson-Piercy; Christian Selinger
Journal:  Frontline Gastroenterol       Date:  2021-09-21

2.  Ustekinumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk, and infant serum.

Authors:  Jumpei Saito; Kayoko Kaneko; Hiroyo Kawasaki; Takeshi Hayakawa; Naho Yakuwa; Tomo Suzuki; Haruhiko Sago; Akimasa Yamatani; Atsuko Murashima
Journal:  J Pharm Health Care Sci       Date:  2022-07-01

Review 3.  Does Folic Acid Protect Patients with Inflammatory Bowel Disease from Complications?

Authors:  Alicja Ewa Ratajczak; Aleksandra Szymczak-Tomczak; Anna Maria Rychter; Agnieszka Zawada; Agnieszka Dobrowolska; Iwona Krela-Kaźmierczak
Journal:  Nutrients       Date:  2021-11-12       Impact factor: 5.717

Review 4.  Immunosuppressive and Immunomodulating Therapy for Atopic Dermatitis in Pregnancy: An Appraisal of the Literature.

Authors:  Sofine Heilskov; Mette S Deleuran; Christian Vestergaard
Journal:  Dermatol Ther (Heidelb)       Date:  2020-11-02

Review 5.  The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding.

Authors:  Katarzyna Romanowska-Próchnicka; Anna Felis-Giemza; Marzena Olesińska; Piotr Wojdasiewicz; Agnieszka Paradowska-Gorycka; Dariusz Szukiewicz
Journal:  Int J Mol Sci       Date:  2021-03-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.